 |
|
Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial
Shapour Omidvari, Shadi Zohourinia, Mansour Ansari, Leila Ghahramani, Mohammad Zare-Bandamiri, Ahmad Mosalaei, Niloofar Ahmadloo, Saeedeh Pourahmad, Hamid Nasrolahi, Sayed Hasan Hamedi, Mohammad Mohammadianpanah
Ann Coloproctol. 2015;31(4):123-130. Published online 2015 Aug 31 DOI: https://doi.org/10.3393/ac.2015.31.4.123
|
|
Citations to this article as recorded by
 Brachytherapy of rectal cancer: comparative characteristics of techniques (review)
Roman V. Novikov, Sergey N. Novikov
Koloproktologia.2023; 22(3): 158. CrossRef Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes
N. Hearn, D. Atwell, K. Cahill, J. Elks, D. Vignarajah, J. Lagopoulos, M. Min
Clinical Oncology.2021; 33(1): e1. CrossRef Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus
Zahra Siavashpour, Farzad Taghizadeh-Hesary, Afshin Rakhsha
Journal of Gastrointestinal Cancer.2020; 51(3): 800. CrossRef Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review
F. Roeder, E. Meldolesi, S. Gerum, V. Valentini, C. Rödel
Radiation Oncology.2020;[Epub] CrossRef Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study
Sare Hosseini, NamPhong Nguyen, Mohammad Mohammadianpanah, Sepideh Mirzaei, Ali Mohammad Bananzadeh
Journal of Gastrointestinal Cancer.2019; 50(4): 716. CrossRef A systematic review comparing radiation toxicity after various endorectal techniques
An-Sofie Verrijssen, Thirza Opbroek, Murillo Bellezzo, Gabriel P. Fonseca, Frank Verhaegen, Jean-Pierre Gerard, Arthur Sun Myint, Evert J. Van Limbergen, Maaike Berbee
Brachytherapy.2019; 18(1): 71. CrossRef Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
Richard Garfinkle, Sebastian Lachance, Te Vuong, Alexandre Mikhail, Vincent Pelsser, Adrian Gologan, Nancy A. Morin, Carol-Ann Vasilevsky, Marylise Boutros
Diseases of the Colon & Rectum.2019; 62(3): 294. CrossRef Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
Mark T.W. Teo, Lucy McParland, Ane L. Appelt, David Sebag-Montefiore
International Journal of Radiation Oncology*Biology*Physics.2018; 100(1): 146. CrossRef Colorectal Cancer Staging Using Three Clustering Methods Based on Preoperative Clinical Findings
Saeedeh Pourahmad, Soudabeh Pourhashemi, Mohammad Mohammadianpanah
Asian Pacific Journal of Cancer Prevention.2016; 17(2): 823. CrossRef Lentivirusâmediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells
An Liu, Chenggang Huang, Jia Xu, Xuehong Cai
Cancer Medicine.2016; 5(9): 2417. CrossRef Is Low-Dose-Rate Endorectal Brachytherapy a New Treatment Method for Locally Advanced Distal Rectal Cancer?
Seung Hyuk Baik
Annals of Coloproctology.2015; 31(4): 115. CrossRef
|